Heron Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.47 |
Market Cap |
$1.45 B |
Shares Outstanding |
79.19 M |
Public Float |
77.53 M |
Address |
4242 Campus Point Court San Diego California 92121 United States |
Employees | - |
Website | http://www.herontx.com |
Updated | 07/08/2019 |
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. |